GENB Generate Biomedicines, Inc.

GENB Generate Biomedicines, Inc.

Healthcare · Biotechnology

Market read

POC $16.11 · VWAP $14.78 · -18.2% vs 12m avg buyer

too-young gaps: stablechurn: quiet as of

Insiders quiet 0 buy / 0 sell · Form 4, 90d

Coverage

1 related campaign

Watchlists @biotech-capital-cycle

GENB Price Structure

Loading chart…

Loading timeframes…

Peers

Every watchlist GENB belongs to, members best 30-day change first — GENB highlighted in place. Each pill: 30d change, 1d/7d, and a close spark over the last 30 calendar days (~21 sessions); hover for price, RSI, and the full chart.

@biotech-capital-cycle
View watchlist →
NAUT+111.9% -4.6%1d -8.4%7d QSI+53.4% -14.5%1d -26.8%7d DNA+45.5% -12.7%1d -21.0%7d PACB+29.1% -11.7%1d -25.8%7d MTD+17.7% -1.0%1d +4.7%7d CERT+15.3% -3.0%1d +2.6%7d ILMN+14.7% -2.0%1d -5.6%7d FTRE+12.6% -1.1%1d +7.9%7d A+12.5% -1.5%1d +1.4%7d DHR+9.9% -1.1%1d +4.2%7d CRL+9.8% -2.0%1d -0.5%7d RXRX+8.8% -16.6%1d -20.4%7d SEER+6.8% -0.5%1d -7.3%7d TMO+6.4% -0.9%1d +4.9%7d AVTR+5.2% +2.0%1d +4.8%7d RVTY+4.7% -1.3%1d -1.0%7d WAT+4.4% -1.6%1d +0.7%7d ABSI+2.6% -7.1%1d -18.8%7d RGEN+1.4% -4.8%1d +0.9%7d ABCL+1.1% -6.9%1d -6.0%7d MEDP+0.3% -1.6%1d +1.1%7d IQV-0.7% -1.5%1d +2.7%7d QTRX-1.4% -6.5%1d -12.5%7d ICLR-2.2% -2.8%1d +3.7%7d TXG-3.9% -3.5%1d -13.4%7d AGIO-5.0% -3.1%1d -1.5%7d SDGR-5.6% -11.3%1d -17.2%7d XBI-6.4% -3.6%1d -6.2%7d TWST-7.2% -8.1%1d -16.9%7d CDXS-7.5% -8.8%1d -12.1%7d TEM-7.5% -9.0%1d -8.8%7d BRKR-9.7% -3.1%1d -6.9%7d LAB-11.3% -4.5%1d -8.8%7d ALMR-14.0% -7.8%1d 0.0%7d VKTX-14.7% -8.0%1d -11.7%7d GENB-22.9% -7.4%1d -15.7%7d

Next earnings GENB reports in 19 days Nov 5

Last report Aug 6

Reported the quarter ending 2026-06-30: revenue $6M, diluted EPS -$0.52, net income -$67M (SEC filing). Across the print the stock moved -1.0% (close before → first close after).

full note →

Against street estimates

How GENB's reported EPS compared with analyst consensus. Street estimates are single-source vendor consensus (yfinance). Actuals are vendor consensus-basis EPS (often non-GAAP); edgarEps is GAAP diluted from filings — disputed flags large disagreement only. EPS only.

2 quarters on file · newest report Aug 6 · projection Oct 16

Result
Aug 6 -0.49-0.52-5.6%Miss
May 7 -0.51-1.07-111.2%Miss

Recent news

Headlines about GENB from the desk's news pull — links go to the publisher. Not a desk read: the market read above is the desk's own.

pulled 3 days ago · Oct 14

GENB research tape

2 dated scans, research, and events, newest first — the full record. Desk commentary and scheduled prints sit in their own panes.

earnings GENB earnings — 2026-08-06 deep dive GENB — Deep Dive (Generate Biomedicines)
Types
Aug 6 Catalyst GENB earnings
GENB
Jun 4 Deep Dive GENB (Generate Biomedicines)
GENB#biotech-capital-cycle